FME has been the subject of a number of other reports. Barclays set a price target of €68.00 ($71.58) on shares of Fresenius Medical Care AG & Co. KGaA in a Tuesday, April 26 report. Deutsche Bank Aktiengesellschaft set a target price of €58.00 ($61.05) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, March 22 report. Jefferies Financial Group set a price target of €53.00 ($55.79) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, February 22 research note. Stifel Nicolaus set a €60.00 ($63.16) price target on Fresenius Medical Care AG & Co. KGaA in a Friday, February 4 research note. Finally, UBS Group set a target price of €75.00 ($78.95) on Fresenius Medical Care AG & Co. KGaA in a Tuesday, April 26 research report. One research analyst rated the stock with a sell rating, four gave the company a hold rating and five gave the company a buy rating. Based on data from MarketBeat, the stock currently has a consensus rating of Hold and a consensus price target of €64.94 ($68.35).
Action Fresenius Medical Care AG & Co. KGaA opened at €59.10 ($62.21) on Thursday. Fresenius Medical Care AG & Co. KGaA has a 1-year minimum of €50.98 ($53.66) and a 1-year maximum of €71.14 ($74.88). The company’s 50-day moving average price is $59.75 and its 200-day moving average price is $58.56. The company has a debt ratio of 95.29, a current ratio of 1.10 and a quick ratio of 0.76. The stock has a market capitalization of $17.32 billion and a P/E ratio of 17.53.
Fresenius Medical Care AG & Co. KGaA Company Profile (Get a rating)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.
Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .